Concepedia

Emi Terasawa

ET

Statistics

Publications

4

Citations

114

H-Index

4

Active since

2018

Affiliations

Analysis Group (United States)(Current)

Duke University

Emi Terasawa is an author at Analysis Group (United States) specializing in pharmacotherapy, medicine, and oncology.

Publications per year

2018–2021

4

Publications

4

Clinical Outcomes and Health-Care Resource Use Associated With Reslizumab Treatment in Adults With Severe Eosinophilic Asthma in Real-World Practice

Michael E. Wechsler, Stephen P. Peters, Tanisha Hill et al. · CHEST Journal · 2020 · 39 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +14

Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer

Susan Halabi, Shan Jiang, Emi Terasawa et al. · The Journal of Urology · 2021 · 36 citations · Full text

Medicine, Oncology, Pharmacology +16

Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index

Lieneke F.M. Ariëns, Abhijit Gadkari, Harmieke van Os‐Medendorp et al. · Acta Dermato Venereologica · 2019 · 21 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17

Drivers of treatment patterns in patients with chronic lymphocytic leukemia stopping ibrutinib or idelalisib therapies

Anthony R. Mato, Jennifer C. Samp, Geneviève Gauthier et al. · Cancer Biology & Therapy · 2018 · 18 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

1–4 of 4